Day: August 1, 2025

WARREN, N.J., Aug. 01, 2025 (GLOBE NEWSWIRE) — Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today released a letter to stockholders. Dear Fellow Stockholders, Tevogen has rapidly evolved from a biotechnology innovator into a dynamic enterprise expanding into artificial intelligence through Tevogen.AI. Our mission remains steadfast: delivering clinically impactful, economically accessible therapies by leveraging cutting-edge science and technology. Tevogen has become a recognized name for its business philosophy of social responsibility, patient affordability and cost efficiency. In under five years, we validated our proprietary ExacTcell™ platform, completed successful proof-of-concept clinical trial of the platforms first product, established drug discovery R&D center — currently in the process...

Funds will support advancement of Tevogen.AI, the Company’s artificial intelligence–driven drug discovery initiative. The $1 million is part of up to $10 million in previously announced non‑dilutive grant funding from KRHP LLC.WARREN, N.J., Aug. 01, 2025 (GLOBE NEWSWIRE) — Tevogen Bio Holdings Inc. (“Tevogen” or the “Company) (Nasdaq: TVGN), today announced that it expects to receive $1 million in grant funding to advance Tevogen.AI, its artificial intelligence–powered drug discovery and development program. The funding would be provided under the previously announced grant agreement with KRHP LLC, under which Tevogen received $2 million in January 2025 and may receive up to an additional $8 million, for an aggregate of $10 million in non-dilutive funding. KRHP LLC is affiliated with an existing Tevogen investor. The Company...

Banco Comercial Português, S.A. informs about 2025 EU-Wide Stress Test ResultsAttachment2025 08 01 Stress Tests_EN

TORONTO, Aug. 01, 2025 (GLOBE NEWSWIRE) — Mandalay Resources Corporation (“Mandalay” or the “Company”) (TSX: MND, OTCQB: MNDJF) is pleased to announce that the Supreme Court of British Columbia has issued a final order approving the previously announced plan of arrangement under the Business Corporations Act (British Columbia) (the “Arrangement”), pursuant to which Alkane Resources Limited (“Alkane”) will acquire all of the issued and outstanding common shares of Mandalay (“Mandalay Shares”). Under the Arrangement, shareholders of Mandalay will be entitled to receive, for each Mandalay Share held, 7.875 fully paid ordinary shares in the capital of Alkane. The receipt of the Final Order was the final substantive condition to closing the Arrangement. The Arrangement is expected to close on August 5, 2025. For Further Information Mandalay...

MERIDIAN, Idaho, Aug. 01, 2025 (GLOBE NEWSWIRE) — PCS Edventures!, Inc. (“PCSV”), a leading provider of TK-12 Science, Technology, Engineering and Mathematics (“STEM”) education programs, today announced that it has repurchased 3,736,170 of its outstanding shares on the open market in the period from July 07, 2025, up to and including July 28, 2025. The shares were repurchased at an average price of $0.0991 for a total consideration of $370,430.26. These repurchases were made as part of the 10 million share buyback program announced on April 10, 2025. The total number of shares repurchased under this program to date is 4,132,979 shares, for a total consideration of $425,234.71, which includes one private transaction for 284,959 shares at $0.14 and one private transaction for 11,850 shares at $0.11. PCS Edventures!, Inc. intends...

BOCA RATON, FL, Aug. 01, 2025 (GLOBE NEWSWIRE) — DeFi Development Corp. (Nasdaq: DFDV) (the “Company”) today announced it will host a live X Spaces conversation on Monday, August 4, 2025, at 1:30 p.m. Eastern Time, titled “July 2025 Business Recap & AMA.” The event will offer participants a detailed review of the Company’s recent business developments, key milestones, and strategic initiatives undertaken in July 2025. Additionally, the Company’s leadership team will host an interactive Ask-Me-Anything (AMA) session, providing investors and community members an opportunity to have their questions addressed. Participants can join the live event by visiting DeFi Development Corp.’s official X (formerly Twitter) account at the scheduled time. A recording of the conversation will be made available shortly after the event concludes. Join...

All amounts expressed in U.S. dollars TORONTO, Aug. 01, 2025 (GLOBE NEWSWIRE) — Barrick Mining Corporation (NYSE:B)(TSX:ABX) today held its Annual Sustainability Update, an important forum for direct engagement with stakeholders focused on sustainability performance and priorities. The webinar follows the recent publication of the company’s comprehensive 2024 Sustainability Report and highlights key achievements across Barrick’s global operations. The company continues to advance foundational growth projects designed to create long-term value for all stakeholders through genuine partnerships. Barrick’s sustainability priorities include comprehensive reporting against the UN Sustainable Development Goals (SDGs), maintaining its unwavering commitment to workplace safety, and proactive forecasting and management of greenhouse gas...

Susvimo is the only continuous delivery treatment to provide reliable, long-term vision outcomes in nAMD, the leading cause of vision loss in people over the age of 60 With two refills per year, Susvimo maintained vision and stabilised the retina for five years, with durability maintained in approximately 95% of patients Susvimo was well tolerated over five years and has a well-characterised safety profileBasel, 01 August 2025 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today new, five-year efficacy, safety and durability data from the Phase III Portal study, a long-term extension of the Phase III Archway study, of Susvimo® (ranibizumab injection) for the treatment of people with nAMD.1 Results show that Susvimo’s immediate and predictable durability was sustained over five years, with approximately 95% of people receiving...